Pharmaceutical industry funding has transformed much grassroots community activism on health into corporate-sponsored advocacy. This critical commentary outlines recent evidence about industry funding of patient advocacy groups, offers a commentary on the history of grassroots activism appearing in this issue of the journal, and calls for greater scrutiny of the impacts and ethics of such sponsorship.
Ray Moynihan. Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company. Journal of bioethical inquiry. 2020 Mar;17(1):61-63
PMID: 32212056
View Full Text